CH468985A - Verfahren zur Herstellung von 19-nor- 4,9(10)-Steroiden - Google Patents
Verfahren zur Herstellung von 19-nor- 4,9(10)-SteroidenInfo
- Publication number
- CH468985A CH468985A CH759765A CH759765A CH468985A CH 468985 A CH468985 A CH 468985A CH 759765 A CH759765 A CH 759765A CH 759765 A CH759765 A CH 759765A CH 468985 A CH468985 A CH 468985A
- Authority
- CH
- Switzerland
- Prior art keywords
- steroids
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX7727364 | 1964-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH468985A true CH468985A (de) | 1969-02-28 |
Family
ID=19743026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH759765A CH468985A (de) | 1964-06-01 | 1965-06-01 | Verfahren zur Herstellung von 19-nor- 4,9(10)-Steroiden |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3277122A (de) |
| CH (1) | CH468985A (de) |
| DE (1) | DE1493054C3 (de) |
| FR (1) | FR1435502A (de) |
| GB (1) | GB1090242A (de) |
| NL (2) | NL6506952A (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3370071A (en) * | 1965-06-01 | 1968-02-20 | Merck & Co Inc | 3-keto-13beta-alkyl-17beta-acetyl-gona-4, 9-dienes and process |
| CH488682A (de) * | 1965-07-30 | 1970-04-15 | Ciba Geigy | Verfahren zur Herstellung von 4,9,11-Trienen der 19-Nor-androstanreihe |
| FR2077877B1 (de) * | 1970-02-20 | 1974-02-01 | Roussel Uclaf | |
| US3761591A (en) * | 1970-02-20 | 1973-09-25 | Roussel Uclaf | Novel pregnadiene |
| US3919267A (en) * | 1970-03-03 | 1975-11-11 | Roussel Uclaf | 13{62 -ethyl-17{60 -methyl-18,19-dinor-{66 {hu 4,9{b -pregnadiene-3,20-dione |
| NL7710462A (nl) * | 1977-09-26 | 1979-03-28 | Akzo Nv | Werkwijze voor het bereiden van nieuwe steroiden van de pregnaanreeks. |
-
0
- NL NL125068D patent/NL125068C/xx active
-
1964
- 1964-10-23 US US406181A patent/US3277122A/en not_active Expired - Lifetime
-
1965
- 1965-05-14 GB GB20492/65A patent/GB1090242A/en not_active Expired
- 1965-05-25 DE DE1493054A patent/DE1493054C3/de not_active Expired
- 1965-05-31 FR FR18957A patent/FR1435502A/fr not_active Expired
- 1965-06-01 CH CH759765A patent/CH468985A/de unknown
- 1965-06-01 NL NL6506952A patent/NL6506952A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB1090242A (en) | 1967-11-08 |
| NL6506952A (de) | 1965-12-02 |
| FR1435502A (fr) | 1966-04-15 |
| NL125068C (de) | |
| DE1493054A1 (de) | 1969-06-12 |
| DE1493054C3 (de) | 1973-01-04 |
| US3277122A (en) | 1966-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH482713A (de) | Verfahren zur Herstellung von Perhydro-1,2,4-thiadiazindioxyden(1,1) | |
| CH460027A (de) | Verfahren zur Herstellung von Spiro-steroid-6,3'-1-pyrazolinen | |
| CH451103A (de) | Verfahren zur Herstellung von 1,4-Dichlortetrafluorbenzol | |
| AT257570B (de) | Verfahren zur Herstellung von 1,2,4-Trimethyl-5-isopropylbenzol | |
| CH457432A (de) | Verfahren zur Herstellung von 2-Hydroxyäthyl-6,8-didesoxy-6-(1-methyl-4-propyl-pyrrolidin-carboxamido)-7-O-methyl-1-thio-D-erythro-D-galacto-octopyranosid | |
| CH468985A (de) | Verfahren zur Herstellung von 19-nor- 4,9(10)-Steroiden | |
| CH486474A (de) | Verfahren zur Herstellung von 1,2,3,6,7,11b-Hexahydro-4H-pyrazino-(2,1-a)-isochinolinen | |
| AT269377B (de) | Verfahren zur Herstellung von 3-Oxo-13β-alkyl-17β-hydroxy-17α-äthinylgona-5(10), 9(11)-dienen | |
| CH481081A (de) | Verfahren zur Herstellung von 1,2B-Methylensteroiden | |
| CH451171A (de) | Verfahren zur Herstellung von 1,3,4-Oxdiazolen | |
| CH540896A (de) | Verfahren zur Herstellung von 15,16B-Methylensteroiden | |
| CH479567A (de) | Verfahren zur Herstellung von Androst- bzw. Östr-4-en-17B-yloxy-trialkylsilanen | |
| CH460743A (de) | Verfahren zur Herstellung von 3',4',5'-Trimethoxy-3-aminoacrylophenonen | |
| CH441334A (de) | Verfahren zur Herstellung von N,N'-Disulfonyl-1,3-diazacycloalkanen | |
| CH472397A (de) | Verfahren zur Herstellung von 6-Halogen-1a,2a-methylen-16a-methyl- 4,6-pregnadien-17-ol-3,20-dionen | |
| AT260205B (de) | Verfahren zur Herstellung von 2,2,6,6-Tetrachlorcylochexanon | |
| CH467244A (de) | Verfahren zur Herstellung von L-a-Methyl-(3,4-disubstituierten-phenyl)-alaninen | |
| CH451195A (de) | Verfahren zur Herstellung von 2-Chlor-4H-1,3,2-dioxaphosphorin-4-one | |
| CH483409A (de) | Verfahren zur Herstellung von 19-Hydroxy- 4-3-ketosteroiden | |
| AT254841B (de) | Verfahren zur Herstellung von 2-Chlorbuten-(2) | |
| AT254840B (de) | Verfahren zur Herstellung von trans-2-Chlorbuten-(2) | |
| AT278746B (de) | Verfahren zur Herstellung von 1,2,4-Trimethyl-5-isopropylbenzol | |
| CH459191A (de) | Verfahren zur Herstellung von 17a-substituierten 1,1-Äthylen- 2-5a-androsten-17B-olen | |
| CH472419A (de) | Verfahren zur Herstellung von substituierten 3,4-Dihydro-2-benzothio-pyranen | |
| CH455761A (de) | Verfahren zur Herstellung von 14a-Hydroxy-steroiden |